What does this research mean for the field?

The global burden of non-melanoma skin cancer (NMSC) is increasing, with 56,913 deaths and a reduction of 1,212,872 disability-adjusted life years (DALYs) globally in 2021. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to assess the global and regional burden of nonmelanoma skin cancer from 1990 to 2021.

March 10, 2026Discover OncologyOpen Access

Global regional and national burden of nonmelanoma skin cancer from 1990 to 2021 based on the global burden of disease 2021 study

View Full Paper

Ask AI

Bookmark

Authors

YDYuzhu DaiThird Affiliated Hospital of Southern Medical University XLXinyan LiuThird Affiliated Hospital of Southern Medical University HTHongfeng TangThird Affiliated Hospital of Southern Medical University

Discussion

Member takes

Implication

Analysis reveals rising incidence and mortality of nonmelanoma skin cancer globally, indicating urgent public health needs.

Key Points

This research aims to assess the global and regional burden of nonmelanoma skin cancer from 1990 to 2021.
Extracted data from the Global Burden of Disease study
Analyzed incidence, prevalence, and mortality rates
Used linear regression models for trend analysis
Conducted frontier analyses for achievable burden metrics
56,913 deaths and 1,212,872 DALYs attributed to NMSC in 2021
Age-standardized prevalence increased from 18.42 to 32.51 cases per 100,000 individuals
Higher prevalence in men and in high SDI regions
Mortality rates higher in low SDI regions
Countries with higher HDI have lower mortality rates and DALYs for NMSC

Cite This Study

Dai et al. (2026) studied this question.

synapsesocial.com/papers/69af955970916d39fea4cc16 https://doi.org/10.1007/s12672-026-04769-9

View Full Paper

Ask AI

Bookmark

Global regional and national burden of nonmelanoma skin cancer from 1990 to 2021 based on the global burden of disease 2021 study

Discussion

Member takes

Implication

Key Points

Cite This Study

Global regional and national burden of nonmelanoma skin cancer from 1990 to 2021 based on the global burden of disease 2021 study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider